Briacell Therapeutics Corp T.BCT

Alternate Symbol(s): BCTX | BCTXW

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. Bria-IMT, its Phase 3 lead candidate, is a patented, off-the-shelf, cell-based, targeted immunotherapy that activates the patient’s immune system to specifically kill cancer cells without harming other cells. The Company is advancing its Bria-IMT targeted immunotherapy in combination with an immune check point inhibitor (Retifanlimab) in a pivotal Phase 3 study in metastatic breast cancer. It is also developing personalized off-the-shelf immunotherapies, Bria-OTS and Bria-OTS+, which provides a platform technology to develop personalized off-the-shelf immunotherapies for numerous types of cancer, and a soluble CD80 protein therapeutic which act both as a stimulator of the immune system, as well as an immune checkpoint inhibitor. Its pipeline also includes Bria-IMT + CPI, Bria-BRES/BRES+, Bria-PROS+, Bria-LUNG+ and Bria-MEL+.

TSX:BCT - Post by User

Briacell Therapeutics Corp

Bullboard Posts

Comment by newrelic07on Jun 17, 2015 1:00pm

64 Views

Post# 23840150

RE:TLT is far behind in trials but way ahead in market cap

imo Dr. Wiseman is more concerned with the science behind Briavax and share price and marketing takes a back seat. The new ceo is probably getting his desk in order so to speak and will begin marketing the stock soon. As more people find out about bct the sp will rise. This is amazing and only needs more eyes on it. I've been following Briacell for a few months and am fortunate to have gotten some at .24 All my dd has been positive this will move soon. glta

Bullboard Posts

Arbor Metals completes Phase 1 drilling at Jarnet lithium project